Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $10.76 in the prior trading day, Roivant Sciences Ltd (NASDAQ: ROIV) closed at $10.67, down -0.84%. In other words, the price has decreased by -$0.84 from its previous closing price. On the day, 4.28 million shares were traded. ROIV stock price reached its highest trading level at $10.89 during the session, while it also had its lowest trading level at $10.605.
Ratios:
Our goal is to gain a better understanding of ROIV by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 37.91 and its Current Ratio is at 37.91. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $17.
On January 05, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $20.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $14.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $14 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 07 ’25 when Ramaswamy Vivek sold 625,000 shares for $11.18 per share. The transaction valued at 6,987,500 led to the insider holds 39,174,611 shares of the business.
Ramaswamy Vivek sold 273,959 shares of ROIV for $3,142,310 on May 06 ’25. The 10% Owner now owns 39,799,611 shares after completing the transaction at $11.47 per share. On May 07 ’25, another insider, Ramaswamy Vivek, who serves as the 10% Owner of the company, bought 625,000 shares for $11.18 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ROIV now has a Market Capitalization of 7613568000 and an Enterprise Value of 2913876736. For the stock, the TTM Price-to-Sale (P/S) ratio is 78.04 while its Price-to-Book (P/B) ratio in mrq is 1.48. Its current Enterprise Value per Revenue stands at 23.77 whereas that against EBITDA is -2.43.
Stock Price History:
The Beta on a monthly basis for ROIV is 1.16, which has changed by -0.0648554 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, ROIV has reached a high of $13.06, while it has fallen to a 52-week low of $8.73. The 50-Day Moving Average of the stock is 1.10%, while the 200-Day Moving Average is calculated to be -5.20%.
Shares Statistics:
The stock has traded on average 6.66M shares per day over the past 3-months and 6043000 shares per day over the last 10 days, according to various share statistics. A total of 719.63M shares are outstanding, with a floating share count of 439.45M. Insiders hold about 38.41% of the company’s shares, while institutions hold 69.16% stake in the company. Shares short for ROIV as of 1745971200 were 52735015 with a Short Ratio of 7.92, compared to 1743379200 on 45101301. Therefore, it implies a Short% of Shares Outstanding of 52735015 and a Short% of Float of 9.91.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
